US FDA Looks To Resume Unannounced Inspections In India And China

After lapsing due to COVID-19, an unannounced foreign inspection pilot program is on track to resume in 2022, “despite challenges and constraints of travel.”

US FDA ramping up inspections in China and India • Source: Alamy

More from Manufacturing

More from Compliance